Skip to main content

Advertisement

Log in

Diagnosis and Management of Pernicious Anemia

  • Stomach and Duodenum (Joseph R. Pisegna, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Pernicious anemia is a macrocytic anemia due to cobalamin deficiency, which is the result of intrinsic factor deficiency. Pernicious anemia is associated with atrophic body gastritis, whose diagnostic criteria are based on the histologic evidence of gastric body atrophy associated with hypochlorhydria. Serological markers suggesting the presence of oxyntic mucosa damage are increased levels of fasting gastrin and decreased levels of Pepsinogen I. Without the now obsolete Schilling’s test, intrinsic factor deficiency may not be proven, and gastric intrinsic factor output after pentagastric stimulation has been proposed. Intrinsic factor autoantibodies are useful surrogate markers of pernicious anemia. The management of patients with pernicious anemia should focus on the life-long replacement treatment with cobalamin and the monitoring to early diagnose an eventual onset of iron deficiency. Moreover, these patients should be advised about possible gastrointestinal long-term consequences, such as gastric cancer and carcinoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Toh BH, Gleeson PA, Whittingham S, van Driel IR. Autoimmune gastritis and pernicious anemia. In: Rose NR, Mackay IR, editors. The Autoimmune diseases, 3rd edition. Academic Press; 1998. 459–76.

  2. Bergman MP, Faller G, D’Elios MM, et al. Gastric autoimmunity. In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: physiology and genetics. Washington: ASM Press; 2001. Chapter 36.

    Google Scholar 

  3. De Block CEM, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes. A clinically oriented review. J Clin Endocrinol Metab. 2008;93:363–71.

    Article  PubMed  Google Scholar 

  4. Lahner E, Centanni M, Agnello G, et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med. 2008;121:136–41.

    Article  PubMed  Google Scholar 

  5. Ungar B, Mathwes JD, Tait BD, Cowling DC. HLA-DR patterns in pernicious anaemia. BMJ. 1981;282:768–70.

    Article  PubMed  CAS  Google Scholar 

  6. Amedei A, Bergman MP, Appelmelk BJ, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ −ATPase in human gastric autoimmunity. J Exp Med. 2003;198:1147–56.

    Article  PubMed  CAS  Google Scholar 

  7. • Lahner E, Spoletini M, Buzzetti R, et al. HLA-DRB1*03 and DRB1*04 are associated with atrophic body gastritis in an Italian population. Dig Liver Dis. 2010;42:854–9. This study shows that genotypes overlapping with those reported in other autoimmune diseases are associated with autoimmune gastritis, suggesting a common immunological cluster and supporting the role of a genetic susceptibility for autoimmunity in PA.

    Article  PubMed  CAS  Google Scholar 

  8. Fernando MM, Stevens CR, Walsh EM, et al. Defining the role of the MCH in autoimmunity: a review and pooled analysis. PloS Genet. 2008;4:e1000024.

    Article  PubMed  Google Scholar 

  9. Babior BM. Erythrocyte disorders: anemias related to disturbance of DNA synthesis (megaloblastic anemias). In: Williams JW, Beutler E, Erslev AJ, Lichtman MA, editors. Hematology. 4th ed. New York: McGraw-Hill; 1998. p. 453–81.

    Google Scholar 

  10. Werder SF. Cobalamin deficiency, hyperhomocysteinemia and dementia. Neuropsychiatr Dis Treat. 2010;6:159–95.

    Article  PubMed  CAS  Google Scholar 

  11. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350:2068–79.

    Article  PubMed  CAS  Google Scholar 

  12. Annibale B, Lahner E, Negrini R, et al. Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol. 2005;11:5351–57.

    PubMed  Google Scholar 

  13. Tosetti C, Stangellini V, Tucci A, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci. 2000;45:252–7.

    Article  PubMed  CAS  Google Scholar 

  14. Annibale B, Lahner E, Bordi C, et al. Role of Helicobacter pylori infection in pernicious anaemia. Dig Liver Dis. 2000;32:756–62.

    Article  PubMed  CAS  Google Scholar 

  15. Marignani M, Delle Fave G, Mecarocci S, et al. High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anaemia. Am J Gastroenterol. 1999;84:766–72.

    Google Scholar 

  16. Centanni M, Gargano L, Canettieri G, et al. Thyroxine in goiter, Helicobacter pylori, and chronic gastritis. N Engl J Med. 2006;354:1787–95.

    Article  PubMed  CAS  Google Scholar 

  17. Friedlander RD. Racial factor in pernicious anaemia. Am J Med Sci. 1934;187:634.

    Article  Google Scholar 

  18. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097–100.

    Article  PubMed  CAS  Google Scholar 

  19. Carmel R, Johnson CS. Racial patterns in pernicious anemia: early age at onset and increased frequency of intrinsic-factor antibody in black women. N Engl J Med. 1978;298:647–50.

    Article  PubMed  CAS  Google Scholar 

  20. Pedersen AB, Mosbeck J. Morbidity of pernicious anemia. Acta Med Scand. 1969;185:449.

    Article  PubMed  CAS  Google Scholar 

  21. Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673–9.

    Article  PubMed  CAS  Google Scholar 

  22. Carmel R, Weiner JM, Johnson CS. Iron deficiency occurs frequently in patients with pernicious anemia. JAMA. 1987;257:1081–3.

    Article  PubMed  CAS  Google Scholar 

  23. WHO/UNICEF/UNU. Iron deficiency anemia: assessment, prevention, and control. Geneva: World Health Organization; 2001. WHO/NHD/01.3.

    Google Scholar 

  24. Lee EL, Feldman M. Gastritis and other gastropathies. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002. p. 810–27.

    Google Scholar 

  25. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol. 1991;186(suppl):109–16.

    Article  CAS  Google Scholar 

  26. Väänänen H, Vauhkone M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol. 2003;15:885–91.

    Article  PubMed  Google Scholar 

  27. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.

    Article  PubMed  CAS  Google Scholar 

  28. Lahner E, Annibale B. Pernicous anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15:5121–8.

    Article  PubMed  CAS  Google Scholar 

  29. • Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071–9. This study highlights the diagnostic accuracy of the combined assessment of intrinsic factor and parietal cell autoantibodies for the diagnosis of pernicious anemia.

    Article  PubMed  CAS  Google Scholar 

  30. Cattan D. Pernicious anemia: what are the acutal diagnostic criteria? World J Gastroenterol. 2011;17:543–4.

    Article  PubMed  Google Scholar 

  31. Toh BH, Alderuccio F. Parietal cell and intrinsic factor autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL, editors. Autoantibodies. 2nd ed. Amsterdam: Elsevier; 2007. p. 479–86.

    Chapter  Google Scholar 

  32. Ungar B, Whittingham S, Francis CM. Pernicious anaemia: incidence and significance of circulating antibodies to intrinsic factor and parietal cells. Aus Ann Med. 1967;16:226–9.

    CAS  Google Scholar 

  33. Davidson RJL, Atrah HI, Sewell HF. Longitudinal study of circulating antibodies in pernicious anemia. J Clin Pathol. 1989;42:1092–5.

    Article  PubMed  CAS  Google Scholar 

  34. Carmel R. Reassessment of the relative prevalence of antibodies to gastric parietal cell and to intrinsic factor in patients with pernicious anaemia: influence of patient age and race. Clin Exp Immunol. 1992;89:74–7.

    Article  PubMed  CAS  Google Scholar 

  35. Annibale B, Negrini R, Caruana P, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter. 2001;6:225–33.

    Article  PubMed  CAS  Google Scholar 

  36. Carmel R, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and food-cobalamin malabsorption. Dig Dis Sci. 1994;39:309–14.

    Article  PubMed  CAS  Google Scholar 

  37. Cohen H, Weinstein WM, Carmel R. Heterogeneity of gastric histology and function in food cobalamin malabsorption: absence of atrophic gastritis and achlorhydria in some patients with severe malabsorption. Gut. 2000;47:638–45.

    Article  PubMed  CAS  Google Scholar 

  38. Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency. Dtsch Arztebl Int. 2008;105:680–5.

    PubMed  Google Scholar 

  39. Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficiency—an update. Haematologica. 2006;91:1506–12.

    PubMed  CAS  Google Scholar 

  40. Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc. 1994;69:144–50.

    PubMed  CAS  Google Scholar 

  41. Bastrup-Madsed P, Helleberg-Rasmussen I, Norregaard S, et al. Long term therapy of pernicious anemia with the depot cobalamin preparation betolvex. Scand J Haematol. 1983;31:57–62.

    Article  Google Scholar 

  42. Hathcock JN, Troendle GJ. Oral cobalamin for treatment of pernicious anemia? JAMA. 1991;265:96–7.

    Article  PubMed  CAS  Google Scholar 

  43. Lederle FA. Oral cobalamin for pernicious anemia. Medicine’s best kept secret? JAMA. 1991;265:94–5.

    Article  PubMed  CAS  Google Scholar 

  44. Andrès E, Dali-Youcef N, Vogel T, et al. Oral cobalamin (vitamin B(12)) treatment. An update. Int J Lab Hematol. 2009;31:1–8.

    Article  PubMed  Google Scholar 

  45. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992;52:673–5.

    Google Scholar 

  46. Wu M-S, Chen C-J, Lin J-T. Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1878–82.

    Article  PubMed  Google Scholar 

  47. Sjoblom SM, Sipponen P, Miettinen M, et al. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy. 1988;20:52–6.

    Article  PubMed  CAS  Google Scholar 

  48. Annibale B, Azzoni C, Corleto VD, et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol. 2001;13:1449–56.

    Article  PubMed  CAS  Google Scholar 

  49. Kokkola A, Sjöblom S-M, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. Scand J Gastroenterol. 1998;33:88–92.

    Article  PubMed  CAS  Google Scholar 

  50. Vannella L, Sbrozzi-Vanni A, Lahner E, et al. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther. 2011. doi:10.1111/j.1365-2036.2011.04659.x [Epub ahead of print].

  51. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori and the development of gastric cancer. N Engl J Med. 2001;345:784–89.

    Article  PubMed  CAS  Google Scholar 

  52. Eisenbrand G, Adam B, Peter M, et al. Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate- a possible risk factor for gastric carcinogenesis. IARC Sci Publ. 1984;963:68.

    Google Scholar 

  53. Annibale B, Capurso G, Lahner E, et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut. 2003;52:496–501.

    Article  PubMed  CAS  Google Scholar 

  54. Schafer LW, Larson DE, Melton 3rd LJ, et al. Risk of development of gastric carcinoma in patients with pernicious anemia: a population-based study in Rochester, Minnesota. Mayo Clin Proc. 1985;60:444–8.

    PubMed  CAS  Google Scholar 

  55. Lahner E, Bordi C, Cattaruzza MS, et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;22:471–81.

    Article  PubMed  CAS  Google Scholar 

  56. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042–50.

    PubMed  CAS  Google Scholar 

  57. Lahner E, Caruana P, D’Ambra G, et al. First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done? Gastrointest Endosc. 2001;53:443–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gianfranco Delle Fave.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Annibale, B., Lahner, E. & Fave, G.D. Diagnosis and Management of Pernicious Anemia. Curr Gastroenterol Rep 13, 518–524 (2011). https://doi.org/10.1007/s11894-011-0225-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-011-0225-5

Keywords

Navigation